477 related articles for article (PubMed ID: 24113432)
1. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
2. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
3. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
[TBL] [Abstract][Full Text] [Related]
4. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
[TBL] [Abstract][Full Text] [Related]
5. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
[TBL] [Abstract][Full Text] [Related]
6. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
7. Contrast medium injection protocol adjusted for body surface area in combined PET/CT.
Behrendt FF; Rebière M; Goedicke A; Pietsch H; Palmowski K; Kuhl CK; Mottaghy FM; Verburg FA
Eur Radiol; 2013 Jul; 23(7):1970-7. PubMed ID: 23423636
[TBL] [Abstract][Full Text] [Related]
8. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual comparison of contrast media concentrations for combined abdominal and thoracic MDCT.
Behrendt FF; Mahnken AH; Stanzel S; Seidensticker P; Jost E; Günther RW; Mühlenbruch G
AJR Am J Roentgenol; 2008 Jul; 191(1):145-50. PubMed ID: 18562738
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of contrast medium enhancement and [(18)F]-FDG uptake of liver metastasis in PET/CT prior to therapy.
Hundt W; la Fougère C; Vogtmann J; Steinbach S; Burbelko M; Tiling R
Eur J Radiol; 2012 Apr; 81(4):652-7. PubMed ID: 21300504
[TBL] [Abstract][Full Text] [Related]
11. A prospective study comparing different iodine concentrations for triphasic multidetector row CT of the upper abdomen.
Sandstede JJ; Werner A; Kaupert C; Roth A; Jenett M; Harz C; Hahn D
Eur J Radiol; 2006 Oct; 60(1):95-9. PubMed ID: 16879942
[TBL] [Abstract][Full Text] [Related]
12. Identification of the iodine concentration that yields the highest intravascular enhancement in MDCT angiography.
Behrendt FF; Pietsch H; Jost G; Palmowski M; Günther RW; Mahnken AH
AJR Am J Roentgenol; 2013 May; 200(5):1151-6. PubMed ID: 23617503
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhancement in chest multidetector computed tomography: intraindividual comparison of 300 mg/ml versus 400 mg/ml iodinated contrast medium.
Behrendt FF; Plumhans C; Keil S; Mühlenbruch G; Das M; Seidensticker P; Mutscher C; Günther RW; Mahnken AH
Acad Radiol; 2009 Feb; 16(2):144-9. PubMed ID: 19124099
[TBL] [Abstract][Full Text] [Related]
14. Impact of iodine delivery rate with varying flow rates on image quality in dual-energy CT of patients with suspected pulmonary embolism.
Hansmann J; Fink C; Jost G; Pietsch H; Meyer M; Nance JW; Schoepf UJ; Attenberger UI; Schoenberg SO; Henzler T
Acad Radiol; 2013 Aug; 20(8):962-71. PubMed ID: 23746688
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 80 and 120 kVp contrast-enhanced CT for attenuation correction in PET/CT, using quantitative analysis and reporter assessment of PET image quality.
Bernstine H; Sopov V; Yefremov N; Nidam M; Gabbai M; Sosna J; Groshar D
Clin Radiol; 2014 Jan; 69(1):e17-24. PubMed ID: 24156801
[TBL] [Abstract][Full Text] [Related]
16. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
17. [Impact of different iodine concentrations on abdominal enhancement in biphasic multislice helical CT (MS-CT)].
Engeroff B; Kopka L; Harz C; Grabbe E
Rofo; 2001 Oct; 173(10):938-41. PubMed ID: 11588683
[TBL] [Abstract][Full Text] [Related]
18. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
[TBL] [Abstract][Full Text] [Related]
19. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?
Vera P; Ouvrier MJ; Hapdey S; Thillays M; Pesquet AS; Diologent B; Callonec F; Hitzel A; Edet-Sanson A; Ménard JF; Jardin F; Tilly H
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1943-52. PubMed ID: 17694309
[TBL] [Abstract][Full Text] [Related]
20. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients.
Berthelsen AK; Holm S; Loft A; Klausen TL; Andersen F; Højgaard L
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1167-75. PubMed ID: 15909196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
